Trump’s tariffs poised for major test before federal appeals court today
The U.S. Court of Appeals for the Federal Circuit is gearing up to review President Trump’s use of emergency powers to impose tariffs on nearly all U.S. trading partners. This move comes after a lower court ruling that deemed the president lacked the authority to impose 10% tariffs on foreign nations under the International Emergency Economic Powers Act (IEEPA).
Although a three-judge panel initially blocked the tariffs imposed by the president on most countries, the Federal Circuit reinstated them temporarily while the dispute is being considered. The legal battle was initiated by a group of 12 states and five small businesses, making it a significant test of President Trump’s economic agenda. The decision made by the Federal Circuit is expected to be appealed to the Supreme Court, although the outcome from the conservative court remains uncertain.
President Trump has used tariffs as a tool to push trading partners into negotiating deals that he believes are more beneficial to the United States and to address trade imbalances. Since announcing the tariffs on April 2, the administration claims to have reached trade agreements with five Asian countries, the United Kingdom, and the European Union. However, many economists argue that tariffs could lead to increased consumer prices and slower economic growth.
The tariffs announced in early April included a 10% baseline tariff on almost every country, with reciprocal tariffs exceeding the 10% rate on numerous trading partners. While these reciprocal tariffs were initially set to take effect on April 9, President Trump issued a 90-day pause and reduced the rate for countries subject to higher tariffs to 10%. Some of these higher reciprocal duties are scheduled to be reinstated on Friday.
President Trump has indicated that he may raise the blanket tariff rate for nations that do not engage in trade deals with the U.S. to somewhere between 15% and 20%. The cases before the Federal Circuit specifically focus on the Liberation Day tariffs and higher levies on imports from China, Canada, and Mexico, which were implemented to combat the trafficking of fentanyl into the U.S.
It’s worth noting that no president had previously utilized IEEPA to impose tariffs, and the power to levy tariffs is constitutionally vested in Congress. IEEPA does not mention tariffs or duties and has traditionally been employed by presidents to impose economic sanctions on foreign nations.
The legal challenge argues that trade deficits and the flow of illicit drugs across U.S. borders do not constitute national emergencies or threats to national security or the economy. Critics warn that granting the president unlimited power to set tariffs could have far-reaching consequences. Additionally, the challenge asserts that a provision of the Trade Act of 1974 governs the president’s authority to impose tariffs in response to trade deficits, limiting the duties to 15% and a duration of five months.
The Trump administration defends the tariffs, stating that they are necessary to address significant threats to U.S. national security and the economy. They argue that the tariffs have been effective in initiating negotiations on trade deals with U.S. partners and disrupting these negotiations would have adverse consequences.
The Federal Circuit’s ruling on this matter remains pending, and it is uncertain when a decision will be reached. This case underscores the ongoing debate surrounding presidential authority to impose tariffs and the checks and balances within the U.S. government system.
